TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Eclipse Biofarm AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
9,394
|
10,788
|
11,282 |
| Financial expenses |
150
|
133
|
42 |
| Earnings before taxes |
-146
|
93
|
668 |
| EBITDA |
225
|
404
|
869 |
| Total assets |
6,564
|
6,586
|
7,785 |
| Current assets |
5,069
|
4,962
|
6,487 |
| Current liabilities |
4,123
|
3,908
|
5,212 |
| Equity capital |
2,313
|
2,513
|
2,421 |
| - share capital |
130
|
134
|
134 |
| Employees (average) |
5
|
6
|
8 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.2%
|
38.2%
|
31.1% |
| Turnover per employee |
1,879
|
1,798
|
1,410 |
| Profit as a percentage of turnover |
-1.6%
|
0.9%
|
5.9% |
| Return on assets (ROA) |
0.1%
|
3.4%
|
9.1% |
| Current ratio |
122.9%
|
127.0%
|
124.5% |
| Return on equity (ROE) |
-6.3%
|
3.7%
|
27.6% |
| Change turnover |
-1,037
|
-553
|
952 |
| Change turnover % |
-10%
|
-5%
|
9% |
| Chg. No. of employees |
-1
|
-2
|
3 |
| Chg. No. of employees % |
-17%
|
-25%
|
60% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.